Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

CAPS Rating: 3 out of 5

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

Recs

0
Player Avatar theflash222 (26.07) Submitted: 7/18/2010 10:30:33 AM : Outperform Start Price: $14.99 ALNY Score: -54.48

why not

Featured Broker Partners


Advertisement